Safety assessment outside of drug development (e.g. agrichemicals, cosmetics, food additives, etc.)

Welcome!

We are delighted that you have chosen to enhance your educational journey in immuno-safety science by enrolling in this module. The "Safety assessment outside of Drug development (e.g., agrichemicals, cosmetics, food additives, etc.)" lecture is one of a series of 18 lectures included in the Introduction to Immuno-Safety Science module and is led by Dr. Victor Johnson at Burleson Research Technologies. Please review the learning objectives below for more information on what you will learn in this lecture. 
 
If you are new to HESI and would like to learn more about our organization, please take a moment to visit our website at https://hesiglobal.org. 

Target Audience

This course is intended for the science professional or graduate student looking to learn the fundamental science and key considerations that are examined in immune safety assessment. Advanced topics and courses that take a deeper dive into specific scientific areas will be offered and recommended for the more experienced scientist with a firm grasp of the information highlighted in the introduction module.

Learning Objectives

  • The Past – Foundation for Immunotoxicity testing in safety and risk assessment​
  • The Present – Approaches for the generation of comprehensive safety assessment for the immune system​
  • The Future – Adaptation and expansion of immunotoxicity testing driven by the era of in vitro toxicology​
Course summary
Available credit: 
  • 1.00 Participation
Course opens: 
03/22/2022
Course expires: 
03/23/2027
Cost:
$25.00
Part of: 
An Introduction to Immuno-Safety Science
Rating: 
0
Victor Johnson, PhD
Burleson Research Technologies

Available Credit

  • 1.00 Participation

Price

Cost:
$25.00
Please login or register to take this course.

Required Hardware/software

This platform, Ethos CE, works with most modern web browsers (e.g., Chrome, Internet Explorer, MS Edge, Safari). Contact itc@hesiglobal.org if you are having any difficulties with this platform.